Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 1998, p. 322-324, Vol. 5, No. 3
Department of Infectious Diseases,
Received 28 July 1997/Returned for modification 11 November
1997/Accepted 5 February 1998
There is evidence that the treatment of bacterial meningitis with
antibiotics liberates harmful bacterial products in the subarachnoid space (SAS). This enhances meningeal inflammation and in
particular the recruitment of leukocytes into the cerebrospinal fluid
(CSF), which has been shown to be more harmful than beneficial in this disease. In this study, we used a rabbit meningitis model based
on intracisternal injection of live Streptococcus
pneumoniae. Ampicillin (40 mg/kg of body weight given
intravenously [i.v.] 16 h after induction of meningitis) caused
a fivefold increase in CSF leukocytes over a 4-h period. Inhibition of
leukocyte rolling by treatment with the polysaccharide fucoidin (10 mg/kg, i.v.) prevented the enhanced leukocyte extravasation into the
SAS and attenuated the leakage of plasma proteins over the blood-brain barrier. These results suggest that certain polysaccharides that block
leukocyte rolling have the potential to reduce leukocyte-dependent central nervous system damage in bacterial meningitis.
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Polysaccharide Fucoidin Inhibits the Antibiotic-Induced
Inflammatory Cascade in Experimental Pneumococcal
Meningitis
and
*
Corresponding author. Mailing address: Department of
Infectious Diseases, Huddinge Hospital, S-141 86 Huddinge, Sweden.
Phone: 46-8-585 80000. Fax: 46-8-585 81916.
Present address: Astra Pain Control AB, Preclinical R&D, Novum
Unit, S-141 57 Huddinge, Sweden.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»